Feintool International Holding AG (LON:0QLM)

CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	160	178	249	267	230	227
Market Cap Growth	-28.62%	-28.62%	-6.55%	16.05%	1.18%	-3.81%
Enterprise Value	201	226	297	318	336	362
Last Close Price	11.47	12.16	16.61	17.60	29.26	29.00
PE Ratio	-	-	-	18.01	14.76	-
PS Ratio	0.25	0.28	0.32	0.36	0.48	0.56
PB Ratio	0.40	0.45	0.55	0.55	0.84	0.93
P/TBV Ratio	0.54	0.60	0.72	0.72	1.11	1.32
P/FCF Ratio	42.12	46.77	10.31	11.08	7.42	281.52
P/OCF Ratio	2.91	3.23	3.56	5.43	3.74	6.61
EV/Sales Ratio	0.30	0.36	0.38	0.43	0.71	0.89
EV/EBITDA Ratio	9.78	19.39	4.31	4.77	5.66	10.84
EV/EBIT Ratio	-	-	10.63	12.75	11.73	139.43
EV/FCF Ratio	52.75	59.53	12.30	13.22	10.87	448.35
Debt / Equity Ratio	0.27	0.27	0.22	0.23	0.52	0.72
Debt / EBITDA Ratio	5.47	5.47	1.31	1.46	2.09	4.18
Debt / FCF Ratio	27.95	27.95	4.18	4.61	4.58	217.80
Asset Turnover	0.89	0.89	0.98	1.04	0.86	0.71
Inventory Turnover	3.71	3.71	3.75	3.90	3.44	3.40
Quick Ratio	0.94	0.94	1.18	1.02	1.00	0.90
Current Ratio	1.52	1.52	1.93	1.85	1.67	1.34
Return on Equity (ROE)	-9.52%	-9.52%	3.46%	4.01%	6.08%	-1.31%
Return on Assets (ROA)	-3.11%	-3.11%	2.17%	2.17%	3.25%	0.28%
Return on Capital (ROIC)	-4.31%	-4.31%	2.97%	2.95%	4.34%	0.39%
Return on Capital Employed (ROCE)	-	-	4.60%	3.80%	6.60%	0.60%
Earnings Yield	-24.62%	-22.17%	-1.61%	5.55%	6.78%	-1.44%
FCF Yield	2.37%	2.14%	9.70%	9.03%	13.47%	0.36%
Dividend Yield	-	-	0.95%	0.87%	1.38%	-
Payout Ratio	-	-	-	14.90%	-	-
Buyback Yield / Dilution	-0.02%	-0.02%	-32.50%	-126.48%	0.02%	-0.12%
Total Shareholder Return	-	-0.02%	-31.55%	-125.61%	1.41%	-0.12%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.